Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 906
Guide Official Revision Description Reason for Update
Version Date Number Of Change
Conditions, revise language
and insert links to
specification sheets to clarify
criteria for Special Issuance
and follow-up.
2015 01/05/2015 1. Administrative Revise cover page to reflect
the current calendar year.
2014 12/09/2014 1. Medical Policy In Pharmaceuticals, Anti-
hypertensives, revise to state
that the combination use of
beta-blockers and insulin,
meglitinides, or sulfonylurea
is now allowed.
2014 12/09/2014 1. Medical Policy In Pharmaceuticals, Do Not
Issue – Do Not Fly, remove
“Concurrent use of a beta-
blocker plus a sulfonylurea
or insulin or a meglitinide”
from the Do Not Issue listing.
2014 12/02/2014 1. Administrative Review Guide and remove
any erroneous references to
Titmus II Vision Testers (TII,
TIIs). Tester was previously
removed (09/27/13) as
acceptable for airmen.
2014 11/24/2014 1. Administrative In Disease Protocols, review
and adjust table of contents
order.
2014 10/22/2014 1. Medical Policy In Pharmaceuticals,
Diabetes Mellitus Type II –
Medication Controlled (Not
Insulin), revise chart of
Acceptable Combinations of
Diabetes Medications to
include alogliptin (Nesina)
and trade names for
metformin (Glucophage,
Fortament, Glutetza,
Riomet.)
2014 10/20/2014 1. Medical Policy In Pharmaceuticals,
Diabetes Mellitus – Insulin
Treated and in Diabetes
Mellitus – Diabetes Mellitus
Type II – Medication
Controlled (Not Insulin),
revise Pharmaceutical
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
